MMJ gets serious in Australia

Published at Oct 23, 2015, in ASX Biotechs

MMJ PhytoTech (ASX:MMJ) is getting serious about the Australian market, appointing a legal advisor and raising cash as regulatory hurdles in front of a medicinal cannabis industry start to evaporate.

It comes after the Turnbull government announced that it would allow the states to legalise the growth of cannabis for medical purposes, opening the door for a medical cannabis industry to get started.

States including Victoria and News South Wales have already taken key steps in making this a reality, but the commitment to introduce national legislation on the issue is a boon for companies which could potentially play in the space.

MMJ PhytoTech, since the federal move was announced on Friday, has rocketed up by more than 20% to be at 37.5c at the time of writing.

MMJ had previously signalled its intent to investigate the Australian market on the back of positive noises from the Victorian government, but the federal government cooing to the party has triggered firmer action.

It has appointed national legal firm Piper Alderman to act as a regulatory advisor, and raised $2 million via a placement in Europe to fund the move into Australia.

MMJ PhytoTech, which is an ASX-listed company, has has to head to other jurisdictions such as Canada and Israel in order to build a fully-integrated medical cannabis company.

It has a ‘farm to pharma’ strategy, which includes the growing of cannabis; the extraction of key compounds and manufacture of medical products from those compounds; and a research & development capacity.

Managing director Andreas Gedeon said the positive shift in the Australian regulatory environment would provide a unique opportunity for MMJ.

“We’re incredibly supportive of the recent announcement from the federal government and it is this which has driven our decision to expedite our strategy to enter the Australian market,” he said.

“Our background within the medical cannabis sector provides us with the necessary experience and expertise to quickly establish ourselves as a leading player in the domestic space.”

S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.

Conflict of Interest Notice

S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.

Publishers Notice

The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.

Australian ASX Small Cap stocks | Why Finfeed.com is Australia’s leading small cap publication

Founded seven years ago, Finfeed.com is Australia’s leading and longest standing website for investor and finance news, education and expert opinion.

Published by StocksDigital, Finfeed was created to report daily on the comings and goings of ASX listed stocks in the small cap market.

As the first digital publication dedicated specifically to this space, Finfeed soon became the most trusted publication in the market, quickly garnering over two million page views – a number that continues to rise.

Finfeed.com provides its readers with informative articles that tackle the latest in market moving #ASX small cap news, plus exclusive content you won’t find anywhere else. It is aimed at those with an interest in investing, market education, company performance, start-ups and much more.

Finfeed.com is the only media organisation operating under the strength of a Financial Services License and is backed by leading journalists and analysts all with brands of their own.

The website aims to inform, educate and entertain with content that drills down into the heart of financial matters.

Finfeed is a leading source of investor and market information, with everything investors need to know about how to invest written in a way that anyone can understand. 

Over the years, the website has expanded beyond exclusively reporting on small caps, to profile Australia’s leading ASX listed small, mid and large caps as well as some of the country’s most successful CEOs and business leaders to find out what makes them tick.

Every day you will find fresh content covering:

Fast Facts

Over 4,000 articles published

Over 2.3 Million Page Views and counting

Over 10,000 followers on social media

Subscriber list growing by 2% monthly

Thanks for subscribing!

X